HE News Icon

HEOR News Roundup

Tuesday, Mar. 9, 2021 | Issue 543

email icon Twitter icon Facebook icon LinkedIn Icon Subscribe Contact Advertise HEOR & RWE Marketplace

Sponsored by


Novartis and NHS England Agree on Price of Costly SMA Drug; Zolgensma Nearly £1.8 Million per Dose

A recent workshop focusing on RWE (real world evidence) explored the role in observational studies in determining drug effectiveness and in seeking FDA approval.

Read More

ICER Reveals Prescription Drug Cost Sharing Policies, Concludes Many Will Dislike Findings

GOP Avoids Drug Cost Questions During Becerra HHS Hearings

Aetion's Take on RWE Expansion in Europe

Storage a Major Challenge in Genomics Tools for Precision Medicine

HEOR news icon
Featured Events



How leading-edge R&D teams are using RWE

March 10


Maximize your chances of success: Avoid and Mitigate Risk of Failure when Developing Biotherapeutics

March 10


Spotlight ad
Conferences Webinars
Conference of the Week
webinar of the week
Job of the Week
Link of the Week
What we're reading
Syndicated Reports
Healthcare Trends & Forecasts in 2021: Performance Expectations for the Healthcare Industry
Medical Affairs Outsourcing Market 2021 Overview, Trends, Size, Growth and 2028 Future Insights
White Papers
HER Data Enrichment: Enhancing the Value of RWD
Social Determinants of Health in the Time of COVID-19: A 2021 Update
  Customer Service Specialist Divider Principal Scientist, Real World Evidence (RWE) Analytics Divider Senior Research Leader – Patient-Centered Research – Seattle, Bethesda, London Divider Vice President – Evidence Synthesis, HEOR More Jobs  
Post a Job
Partner Banner
TUFTS    IQVIA    Genesis Research    SYAPSE
Evidera  HealthCore VeradigmICONEVIDENCE PARTNERS
PHAROM1Formulary Decisions  Pharmerit   PRMA
JeffersonCYTELNPC   UF
Become a Partner
HealthEconomics Logo  

Share this newsletter!

EMAIL   Twitter   Facebook   LinkedIn